We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$379B
AUM Growth
+$17B
(+4.7%)
Cap. Flow
-$9.66B
Cap. Flow
% of AUM
-2.55%
Top 10 Holdings %
Top 10 Hldgs %
34.6%
Holding
3,324
New
55
Increased
1,013
Reduced
1,512
Closed
70
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$970M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$569M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$462M |
| 4 |
Oracle
ORCL
|
+$420M |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$385M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.46B |
| 2 |
Costco
COST
|
+$914M |
| 3 |
Meta Platforms (Facebook)
META
|
+$891M |
| 4 |
Apple
AAPL
|
+$796M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.65% |
| 2 | Financials | 12.53% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Communication Services | 9.44% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Cytek Biosciences
CTKB
$576M
| $881K | ﹤0.01% |
253,808
| – | – |
|
2652
ArriVent BioPharma
AVBP
$1.4B
| $879K | ﹤0.01% |
47,663
| – | – |
|
2653
BHP
BHP
$213B
| $877K | ﹤0.01% |
15,734
-284
| -2% | -$15.1K |
|
2654
Genie Energy
GNE
$378M
| $877K | ﹤0.01% |
58,641
-95,966
| -62% | -$1.72M |
|
2655
908 Devices
MASS
$288M
| $876K | ﹤0.01% |
99,988
| – | – |
|
|
SHOE
2656
Shoe Station Group
SHOE
$431M
| $872K | ﹤0.01% |
41,929
| – | – |
|
2657
Ranger Energy Services
RNGR
$345M
| $871K | ﹤0.01% |
62,015
| – | – |
|
2658
Preformed Line Products
PLPC
$1.45B
| $861K | ﹤0.01% |
4,388
-340
| -7% | -$59.7K |
|
2659
Tejon Ranch
TRC
$467M
| $861K | ﹤0.01% |
53,859
| – | – |
|
2660
Zumiez
ZUMZ
$347M
| $859K | ﹤0.01% |
43,789
-3,354
| -7% | -$55.4K |
|
2661
Ginkgo Bioworks
DNA
$503M
| $858K | ﹤0.01% |
58,819
+8,241
| +16% | +$98.6K |
|
2662
Standard BioTools
LAB
$311M
| $854K | ﹤0.01% |
657,212
| – | – |
|
2663
Hyster-Yale Materials Handling
HY
$615M
| $854K | ﹤0.01% |
23,161
| – | – |
|
2664
Vanda Pharmaceuticals
VNDA
$310M
| $854K | ﹤0.01% |
171,045
+47,690
| +39% | +$221K |
|
2665
Pulse Biosciences
PLSE
$2.45B
| $853K | ﹤0.01% |
48,185
| – | – |
|
2666
Savara
SVRA
$1.09B
| $846K | ﹤0.01% |
236,835
-83,438
| -26% | -$247K |
|
2667
Haverty Furniture Companies
HVT
$421M
| $842K | ﹤0.01% |
38,391
| – | – |
|
2668
Titan International
TWI
$530M
| $840K | ﹤0.01% |
111,165
-12,093
| -10% | -$108K |
|
2669
Vishay Precision Group
VPG
$1.22B
| $839K | ﹤0.01% |
26,185
| – | – |
|
2670
Regional Management Corp
RM
$392M
| $838K | ﹤0.01% |
21,514
| – | – |
|
|
GNTY
2671
DELISTED
Guaranty Bancshares
GNTY
| $837K | ﹤0.01% |
17,160
| – | – |
|
|
MCHB
2672
Mechanics Bancorp
MCHB
$3.51B
| $833K | ﹤0.01% |
62,572
| – | – |
|
2673
Thryv Holdings
THRY
$184M
| $832K | ﹤0.01% |
68,974
| – | – |
|
2674
Acco Brands
ACCO
$401M
| $830K | ﹤0.01% |
208,100
-42,538
| -17% | -$166K |
|
|
HDSN
2675
Hudson Technologies
HDSN
$259M
| $826K | ﹤0.01% |
83,140
-10,325
| -11% | -$96.9K |
|
Similar funds
VFT
Nuveen's Q3 2025 Portfolio in Review
As of Q3 2025, Nuveen held 3,324 positions worth $379B, up 4.7% from $362B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 3.8%. Nuveen opened 55 new positions and exited 70, leaving the 3,324-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q3 2025 buy was Arm: 911,376 shares worth $129M.
- Nuveen added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2025, an estimated $970M increase.
- Nuveen's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $1.46B.
- Nuveen fully exited Hess in Q3 2025, selling an estimated $162M.
- Nuveen's ten largest holdings make up 35% of its $379B portfolio in Q3 2025.
- Nuveen opened 55 new positions and closed 70 in Q3 2025.
- Nuveen's portfolio value rose 4.7% quarter-over-quarter to $379B.
Based on Nuveen's 13F filing for Q3 2025, filed 12 Nov 2025.